(Q34108752)

English

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

randomized controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

amoxicillin/clavulanic acid

1 reference

based on heuristic

inferred from title

author name string

R Finch

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D Schürmann

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

O Collins

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Kubin

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J McGivern

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H Bobbaers

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J L Izquierdo

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P Nikolaides

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

F Ogundare

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Raz

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P Zuck

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

G Hoeffken

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1746-1754

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Advances in antimicrobial therapy of community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

5 July 2018

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

5 July 2018

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

5 July 2018

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

5 July 2018

Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

5 July 2018

The crisis in antibiotic resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

5 July 2018

Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127227

28 October 2018

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Community-acquired pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical evaluation of antibacterial drugs. Report of a Working Party of the British Society of Antimicrobial Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/12019085

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.46.6.1746-1754.2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34108752&oldid=1562771283"